NEUTROKINE alpha
    13.
    发明授权
    NEUTROKINE alpha 失效
    NEUTROKIN alpha

    公开(公告)号:EP0939804B1

    公开(公告)日:2005-08-17

    申请号:EP96939612.6

    申请日:1996-10-25

    摘要: The present invention relates to a novel Neutrokine alpha protein which is a member of the TNF protein family. In particular, isolated nucleic acid molecules are provided encoding the human Neutrokine alpha protein including soluble forms of the extracellular domain. Neutrokine alpha polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of Neutrokine alpha activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.

    APOPTOSIS INDUCING MOLECULE II
    18.
    发明公开
    APOPTOSIS INDUCING MOLECULE II 失效
    细胞凋亡诱导分子II

    公开(公告)号:EP0904278A1

    公开(公告)日:1999-03-31

    申请号:EP96941944.0

    申请日:1996-10-31

    摘要: The present invention relates to a novel member of the TNF-Ligand superfamily, Apoptosis Inducing Molecule II (AIM II). In particular, isolated nucleic acid molecules are provided encoding the human AIM II protein. AIM II polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of AIM II activity. Also provided are therapeutic methods for treating lymphadenopathy, autoimmune disease, graft versus host disease, and to inhibit neoplasia, such as tumor cell growth.

    摘要翻译: 本发明涉及TNF-配体超家族的新成员,细胞凋亡诱导分子II(AIM II)。 具体而言,提供了编码人AIM II蛋白的分离的核酸分子。 还提供了AIM II多肽以及载体,宿主细胞和用于生产它们的重组方法。 本发明还涉及用于鉴定AIM II活性的激动剂和拮抗剂的筛选方法。 还提供治疗淋巴结病,自身免疫疾病,移植物抗宿主病和抑制瘤形成如肿瘤细胞生长的治疗方法。

    DEATH DOMAIN CONTAINING RECEPTORS
    19.
    发明公开
    DEATH DOMAIN CONTAINING RECEPTORS 失效
    含有死亡受体的受体

    公开(公告)号:EP0898576A1

    公开(公告)日:1999-03-03

    申请号:EP96941942.0

    申请日:1996-10-17

    摘要: The present invention relates to novel Death Domain Containing Receptor (DR3 and DR3-V1) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR3 and DR3-V1 proteins. DR3 and DR3-V1 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR3 and DR3-V1 activity.

    摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族成员的新型含有死亡结构域的受体(DR3和DR3-V1)蛋白。 具体而言,提供了编码人DR3和DR3-V1蛋白的分离的核酸分子。 还提供了DR3和DR3-V1多肽以及载体,宿主细胞和用于生产它们的重组方法。 本发明进一步涉及用于鉴定DR3和DR3-V1活性的激动剂和拮抗剂的筛选方法。

    NEUTROKINE alpha
    20.
    发明授权
    NEUTROKINE alpha 失效
    Neutrokine阿尔法

    公开(公告)号:EP0939804B2

    公开(公告)日:2011-06-15

    申请号:EP96939612.6

    申请日:1996-10-25

    摘要: The present invention relates to a novel Neutrokine alpha protein which is a member of the TNF protein family. In particular, isolated nucleic acid molecules are provided encoding the human Neutrokine alpha protein including soluble forms of the extracellular domain. Neutrokine alpha polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of Neutrokine alpha activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.